Drugs / MTX
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04134247 Background | Nov 2019 → Nov 2021 | non-Hodgkin lymphoma | Shandong Provincial Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX | “High dose MTX（Central recurrence）：MTX 3.5g／ｍ２,ｄ1” NCT04134247 ↗ |